Sir Mortimer B. Davis - Jewish General Hospital
67
12
16
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
17.9%
12 terminated/withdrawn out of 67 trials
64.7%
-21.8% vs industry average
19%
13 trials in Phase 3/4
9%
2 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (67)
Increasing Physical Contact Between Prenatally Anxious/Depressed Mothers and Their Infants to Improve Maternal Sensitivity.
Role: lead
Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy
Role: lead
Cardiovascular Effects of Music Versus Guided Mindfulness
Role: lead
VR Study Virtual Reality for Patients During Arteriovenous Fistula Surgery
Role: lead
A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery
Role: lead
No Surgery Trial / Two Dose-escalation Strategies
Role: lead
Montreal Immune-Related Adverse Events (MIRAE) Study
Role: lead
Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery
Role: lead
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
Role: lead
CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)
Role: lead
Pilot Study of a New Nerve Grafting Method During Bladder Cancer Surgery to Help Preserve Erections.
Role: lead
Penthrox in Otolaryngology
Role: lead
Hypotension Prediction Index in Postoperative Surgical Patients
Role: lead
Aggressive Smoking Cessation Trial (ASAP)
Role: lead
Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy
Role: lead
Novel Robotic Prostatectomy Technique for Early Urinary Continence
Role: lead
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
Role: lead
Niraparib in High-grade Endometrial Cancer Trial
Role: lead
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
Role: lead
Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
Role: lead